Last reviewed · How we verify

NCT05513196

Bilateral Erector Spinal Plan Block in Postoperative Analgesia After Total Abdominal Hysterectomy

Completed Last updated 10 November 2022
What this trial tests

trial testing Erector spinae plane block (ESPB) in Postoperative Pain in 160 participants. Completed in 1 July 2022.

Timeline
1 January 2022
Primary endpoint
1 July 2022
1 July 2022

Quick facts

Lead sponsorKocaeli University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment160
Start date1 January 2022
Primary completion1 July 2022
Estimated completion1 July 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kocaeli University

Who can join

Adults 40 to 70, female only, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The importance of effective postoperative pain management is well known. Overall, for total abdominal hysterectomy operations are related with severe postoperative pain. The undesired effects of pain can be prevented with multimodal analgesia for the patient. Many regional anesthesia techniques can be preferred for total abdominal hysterectomy. The aim of this study is to investigate postoperative analgesia effect of erector spina plane block for total abdominal hysterectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Erector spinae plane block (ESPB)

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Kocaeli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05513196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing